524 related articles for article (PubMed ID: 28823569)
1. The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets.
Hoppe-Seyler K; Bossler F; Braun JA; Herrmann AL; Hoppe-Seyler F
Trends Microbiol; 2018 Feb; 26(2):158-168. PubMed ID: 28823569
[TBL] [Abstract][Full Text] [Related]
2. Induction of dormancy in hypoxic human papillomavirus-positive cancer cells.
Hoppe-Seyler K; Bossler F; Lohrey C; Bulkescher J; Rösl F; Jansen L; Mayer A; Vaupel P; Dürst M; Hoppe-Seyler F
Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E990-E998. PubMed ID: 28115701
[TBL] [Abstract][Full Text] [Related]
3. Repression of Human Papillomavirus Oncogene Expression under Hypoxia Is Mediated by PI3K/mTORC2/AKT Signaling.
Bossler F; Kuhn BJ; Günther T; Kraemer SJ; Khalkar P; Adrian S; Lohrey C; Holzer A; Shimobayashi M; Dürst M; Mayer A; Rösl F; Grundhoff A; Krijgsveld J; Hoppe-Seyler K; Hoppe-Seyler F
mBio; 2019 Feb; 10(1):. PubMed ID: 30755508
[TBL] [Abstract][Full Text] [Related]
4. Effects of the antifungal agent ciclopirox in HPV-positive cancer cells: Repression of viral E6/E7 oncogene expression and induction of senescence and apoptosis.
Braun JA; Herrmann AL; Blase JI; Frensemeier K; Bulkescher J; Scheffner M; Galy B; Hoppe-Seyler K; Hoppe-Seyler F
Int J Cancer; 2020 Jan; 146(2):461-474. PubMed ID: 31603527
[TBL] [Abstract][Full Text] [Related]
5. PI3K/AKT/mTOR Signaling Regulates the Virus/Host Cell Crosstalk in HPV-Positive Cervical Cancer Cells.
Bossler F; Hoppe-Seyler K; Hoppe-Seyler F
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31058807
[TBL] [Abstract][Full Text] [Related]
6. Roles of E6 and E7 Human Papillomavirus Proteins in Molecular Pathogenesis of Cervical Cancer.
Taghizadeh E; Jahangiri S; Rostami D; Taheri F; Renani PG; Taghizadeh H; Gheibi Hayat SM
Curr Protein Pept Sci; 2019; 20(9):926-934. PubMed ID: 31244421
[TBL] [Abstract][Full Text] [Related]
7. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
8. Virus/Host Cell Crosstalk in Hypoxic HPV-Positive Cancer Cells.
Hoppe-Seyler K; Mändl J; Adrian S; Kuhn BJ; Hoppe-Seyler F
Viruses; 2017 Jul; 9(7):. PubMed ID: 28678198
[TBL] [Abstract][Full Text] [Related]
9. High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway.
Wallace NA; Khanal S; Robinson KL; Wendel SO; Messer JJ; Galloway DA
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768872
[TBL] [Abstract][Full Text] [Related]
10. mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model.
Callejas-Valera JL; Iglesias-Bartolome R; Amornphimoltham P; Palacios-Garcia J; Martin D; Califano JA; Molinolo AA; Gutkind JS
Carcinogenesis; 2016 Oct; 37(10):1014-25. PubMed ID: 27538837
[TBL] [Abstract][Full Text] [Related]
11. The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo.
Jung HS; Erkin OC; Kwon MJ; Kim SH; Jung JI; Oh YK; Her SW; Ju W; Choi YL; Song SY; Kim JK; Kim YD; Shim GY; Shin YK
Int J Cancer; 2012 Apr; 130(8):1925-36. PubMed ID: 21630254
[TBL] [Abstract][Full Text] [Related]
12. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
[TBL] [Abstract][Full Text] [Related]
13. Systematic Analysis of IL-1 Cytokine Signaling Suppression by HPV16 Oncoproteins.
Castagnino P; Kim HW; Lam LKM; Basu D; White EA
J Virol; 2022 Nov; 96(22):e0132622. PubMed ID: 36342298
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
15. Expression of human papillomavirus oncoproteins E6 and E7 inhibits invadopodia activity but promotes cell migration in HPV-positive head and neck squamous cell carcinoma cells.
Kahue CN; Jerrell RJ; Parekh A
Cancer Rep (Hoboken); 2018 Oct; 1(3):e1125. PubMed ID: 32721084
[TBL] [Abstract][Full Text] [Related]
16. Effects of Metformin on the virus/host cell crosstalk in human papillomavirus-positive cancer cells.
Hoppe-Seyler K; Herrmann AL; Däschle A; Kuhn BJ; Strobel TD; Lohrey C; Bulkescher J; Krijgsveld J; Hoppe-Seyler F
Int J Cancer; 2021 Sep; 149(5):1137-1149. PubMed ID: 33844847
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation.
Mittal S; Banks L
Mutat Res Rev Mutat Res; 2017; 772():23-35. PubMed ID: 28528687
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus 16 (HPV 16) E6 but not E7 inhibits the antitumor activity of LKB1 in lung cancer cells by downregulating the expression of KIF7.
Hu Y; Wu MZ; Gu NJ; Xu HT; Li QC; Wu GP
Thorac Cancer; 2020 Nov; 11(11):3175-3180. PubMed ID: 32945133
[TBL] [Abstract][Full Text] [Related]
19. Repression of the human papillomavirus E6 gene initiates p53-dependent, telomerase-independent senescence and apoptosis in HeLa cervical carcinoma cells.
Horner SM; DeFilippis RA; Manuelidis L; DiMaio D
J Virol; 2004 Apr; 78(8):4063-73. PubMed ID: 15047823
[TBL] [Abstract][Full Text] [Related]
20. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
